期刊文献+

单价流感疫苗脂质体干粉细胞免疫研究 被引量:8

Cellular immunity of monovalent influenza vaccine lyophilized liposome
下载PDF
导出
摘要 从细胞免疫水平考察流感疫苗脂质体干粉肺部免疫的免疫原性,以验证在稳定性提高的同时,流感疫苗脂质体干粉肺部免疫原性不低于现行应用的流感疫苗原液腹腔注射免疫。将实验小鼠分为2个大组,每组分为阴性对照组、疫苗脂质体冻干粉组、非脂质体流感疫苗原液组和阳性对照组(n=5)。非脂质体流感疫苗原液组和疫苗脂质体冻干粉组分别以每只6μg血凝素(以H1N1计)肺部灌注免疫,同时以每只6μg非脂质体流感疫苗原液组腹腔免疫作为阳性对照。分别免疫14 d和28 d后,用四甲基偶氮唑盐微量酶反应比色法(MTT法)检测脾淋巴细胞增殖情况,以考察其细胞免疫原性。脂质体肺部免疫可以诱导细胞免疫,且其免疫原性明显高于流感疫苗原液传统腹腔注射免疫组。与流感疫苗原液腹腔注射免疫相比,流感疫苗脂质体干粉通过肺部免疫,细胞免疫效果明显提高。 To evaluate the immunogenicity of the influenza vaccine lyophilized liposomes through cellular immunity,it could be confirm that,with the increasing of the stability,the immunogenicity of the influenza vaccine lyophilized liposomes by pulmonary delivery was better than that of the influenza vaccine non-liposome immunized by intraperitoneal injection.Experimental mice were divided into two groups,and each group was divided into the negative control group,the influenza vaccine lyophilized liposome group,the influenza vaccine non-liposome group,and the positive control group(n=5).The influenza vaccine lyophilized liposome group and the influenza vaccine non-liposome group were immunized with 6 μg hemagglutinin of H1N1 per mouse through pulmonary delivery,and the positive control group was immunized with 6 μg hemagglutinin of H1N1 per mouse through intraperitoneal injection.MTT method was used to measure the spleen cell proliferation after immunization to mice 14 days and 28 days in order to study the immunogenicity of the influenza vaccine lyophilized liposome.The influenza vaccine lyophilized liposome could induce the cellular immunity of mice by pulmonary delivery and the level of the cellular immunity was higher than that of the influenza vaccine non-liposome immunized through intraperitoneal injection.Pulmonary delivery of the influenza vaccine lyophilized liposome could achieve satisfied cellular immunity effect.
出处 《南京工业大学学报(自然科学版)》 CAS 北大核心 2011年第6期102-106,共5页 Journal of Nanjing Tech University(Natural Science Edition)
基金 云南省科技厅应用基础研究面上项目(2008ZC113M)
关键词 流感疫苗脂质体 肺部给药 免疫原性 MTT 细胞免疫 influenza vaccine lyophilized liposome pulmonary delivery immunogenicity MTT cellular immunity
  • 相关文献

参考文献10

二级参考文献46

  • 1靳玄烨,谢吉科,杨艳.脂质体制剂稳定性研究进展[J].河北医科大学学报,2004,25(6):374-376. 被引量:8
  • 2周红蕾,李春玲,王贵平,侯加法.脂质体作为疫苗免疫佐剂的应用研究进展[J].动物医学进展,2006,27(2):34-38. 被引量:7
  • 3Ninomiya A, Riddell M A, Gidding H F. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in miee[J]. Vaccine, 2002, 20(25 - 26) :3123.
  • 4Babai I, Barenholz Y, Zakay R Z. A novel liposomal influenza vaccine (INFLUSOME- VAC) containing hemagglutininneuraminidase and IL-2 or GM - CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains [J]. Vaccine, 2001, 20 ( 3 - 4) :505.
  • 5Ernst W A, Kim H J, Tumpey T M. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitop vaccines[J]. Vaccine ,2006,24(24) ..5 158.
  • 6Wang C Y, Yughes K W, Huang L. Improved cytoplasmic delivery to plant protoplasts via PH2sensitive liposome[J]. Plant Physiol, 1986,8(2) : 179.
  • 7De Haan A, Groen G, Prop J, et al. Mucosal immunoadjuvant activity of liposomes : role of alveolar macrophages [ J ]. Immunology, 1996,89 (4) ,488 - 493.
  • 8Lu D, Hickey AJ. Pulmonary vaccine delivery [ J ]. Expert Rev Vaccines,2007,6 ( 2 ) :213 - 226.
  • 9Amorij JP, Saluja V, Petersen AH,et al. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by sprayfreeze drying induces systemic, mucosal humoral as well as cellmediated immune responses in BALB/c mice [ J ]. Vaccine, 2007,25(52) :8 707 -8 717.
  • 10司传平(SiCP).医学免疫学实验技术[M].北京:人民卫生出版社,2006:2.

共引文献17

同被引文献38

  • 1肖勇翔,陈志祥,陆伟根.阳离子脂质体疫苗佐剂研究进展[J].世界临床药物,2013,34(1):41-48. 被引量:2
  • 2刘建峰,肖琅.吸入给药肺沉积的研究进展[J].武警医学院学报,2005,14(2):133-135. 被引量:5
  • 3周红蕾,李春玲,王贵平,侯加法.脂质体作为疫苗免疫佐剂的应用研究进展[J].动物医学进展,2006,27(2):34-38. 被引量:7
  • 4高立栋,王秀梅,尹铁娜.恶性胸水的局部药物治疗[J].临床医学,1997,17(3):31-34. 被引量:2
  • 5Mowat AM, Viney JL. The anatomical basis of intestinal im- munity [ J ]. Immunol Rev, 1997,156 ( 1 ) : 145 - 166.
  • 6Byun Y, Ohmura M, Fujihashi K, et al. Nasal immunization with E. coil verotoxin 1 ( VT1 ) 2B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies [ J]. Vaccine, 2001,19 (15/16) :2061 - 2070.
  • 7Kompella UB, Lee VHL. Delivery systems for penetration enhancement of peptide and protein drugs: design consid- erations [ J ]. Advanced Drug Delivery Reviews, 1992, 8 (1) :115 -162.
  • 8Walker RI. New strategies for using mucosal vaccination to achieve more effective immunization[ J]. Vaccine, 1994,12 (5) :387 -400.
  • 9Airing CR. Immunologic aspects of liposomes Presentation and processing of liposome protein and phospholipid anti- gens [ J ]. Biochim Biophys Acta, 1992,11 ( 13 ) : 307 - 322.
  • 10Degen WG, Jansen T, Schijns VE. Vaccine adjuvant technology:from mechanistic concepts to practical applications [ J ]. Expert Rev Vaccines, 2003,2( 2 ) :327 - 335.

引证文献8

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部